PARP1 and asthma: PARP1 is a pro-inflammatory master regulator and a driver of acute (LPS-induced) and chronic (asthma) lung inflammation, and its inhibition has been shown to ameliorate disease severity in conditions ranging from septic shock to hepatitis41,53,54.